Injection Pens for Osteoporosis Therapy: More Convenience and Better Compliance

Haselmeier develops and produces innovative injection systems for subcutaneous self-delivery

Studies have shown that effective osteoporosis therapy frequently depends on compliance. After one year, less than half of patients remain compliant with their prescribed treatment: Only 40 percent use the medication in question as prescribed. After two years, this number is just 20 percent. Injection pens for osteoporosis therapy could help patients to use their medication more consistently and therefore significantly improve the efficiency of their treatment.

Injection Pens for Osteoporosis Therapy are Comparable with the Use of Insulin Pens

Based on experience with long-established treatment involving insulin pens, it can be assumed that patients significantly prefer pens over syringes, and even doctors prefer to prescribe injection pens than ready-to-use syringes. In daily use especially, injection pens are more popular among patients thanks to their safe, accurate and discreet use. Since there are already active ingredients that patients are able to deliver themselves subcutaneously with injection pens for osteoporosis therapy, it is now possible to permanently improve the efficiency of treatment.

Download the extended Whitepaper now!

Haselmeier is an experienced development partner: Injection pens for osteoporosis therapy can be created in line with customer specifications

With the development of injection pens for osteoporosis therapy, Haselmeier is able to address and fulfill the requirements of both customers and patients. In the future Haselmeier will hold a pharmaceutical packaging license and will therefore be able to produce ready-to-use injection pens for osteoporosis therapy in small and medium-sized series. This is complemented by a comprehensive array of services: Haselmeier holds a pharmaceutical packaging license and can therefore produce ready-to-use injection pens for osteoporosis therapy in small and medium-sized series.

Haselmeier impresses thanks to reliability of treatment with personalized system solutions. Its products and services inspire customers worldwide thanks to their intelligent control and monitoring, scalability and convenience. Haselmeier has specialized in the development and production of high-quality medical technology for almost 100 years, and is also an experienced partner for innovative injection pens for osteoporosis therapy.

Contact us:
info@haselmeier.com
Wilhelm Haselmeier GmbH & Co. KG
Vaihinger Straße 48, 70567 Stuttgart
www.haselmeier.com
T +49 (0)711 71978 0